Advanced Catheter Technology


Arkis SureFloTM EVD Catheter with Endexo® technology:

The Endexo® molecule is a fluoro-oligomeric polymer that results in a passivated surface, which has been shown in-vitro to reduce platelet adhesion and activation, and thrombus formation on catheter surfaces. Endexo® technology is a permanent additive for polymer lumens, not a coating that depletes. An in-licensed polymer technology, Endexo® has been commercially shown by Angiodynamics and other companies to significantly reduce in-vitro thrombus accumulation by > 80% in a variety of catheters and dialyzers. Arkis plans to introduce the technology in the near future beginning with SureFloTM external ventricular drainage kit, currently pending 510K clearance.


To learn more, visit our Products Overview and Surgical Innovations pages, or contact us for further information.



Contact Us

Address:  2450 E.J. Chapman Drive, Knoxville, TN 37996   |    Tel: (844) 247-5383 (toll free)

 © Arkis Biosciences   |    Privacy   |    Sitemap


Go to top